维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="Neijt"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	ExploratoryphaseⅢstudy of paclitaxel and cisplatin versus paclitaxeland carboplatin in advanced ovarian cancer显示文摘	Neijt JP Engelholm SA Tuxen MK	2000	J Clin On-col2000，18，17：	1
2	Exploratory phase I]I study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer 显示文摘	Neijt JP Engelholm SA Tuxen MK	2000	J Clin Oncol2000，18，30：	1
3	Neurotoxic side effects of cisplatin显示文摘	Harmers FP Gispen WH Neijt JP		0，，03：	1
4	Measuring psychological and physical distress in cancer patients: structure and application of the rottradam symptom check list显示文摘	VAN KNIPPENBERG FCE NEIJT JP	1990	Br J Cancer1990，62，8：	1
5	Exploratory phase Ⅲ study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer显示文摘	Neijt JP Engelholm SA Tuxen MK	2000	J Clin Oncol2000，18，17：	1
6	Measuring psycho- logical and physical distress in cancer patients:structure and application of the Rotterdam Symptom Checklist 显示文摘	de Haes JC van Knippenberg FC Neijt JP	1990	Br J Cancer1990，62，6：	1
7	Measuring psychological and physical distress in cancer patients:structure and application of the Rotterdam Symptom Checklist显示文摘	de Haes JC van Knippenberg FC Neijt JP	1990	Br J Cancer1990，62，6：	1
8	Exploratory phase Ⅲ study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer显示文摘	Neijt JP Engelholm SA Tuxen MK	2000	J Clin Oncol2000，18，17：	1
9	Evaluation of cis-diam-minedichloroplatinum (Ⅱ) (cisplatin) neurotoxicity in rats显示文摘	De Koning P Neijt JP Jennekens FG	1987	Toxicol Appl Pharmacol1987，89，1：	1
10	Evaluation of cis-diamminedichloroplatinum (Ⅱ) (cisplatin) neurotoxicity in rats显示文摘	Koning PD Neijt JP Jennekens FG Gispen WH	1987	Toxicol Appl Pharmacol1987，98，：	1
11	5-HT3 recognition sites in the central and peripheniral nervius system: Autoradiographic and radioligand binding studies 显示文摘	HOYER D WOBER C NEIJT H C	1989	Br J Pharmacol1989，96，1：	1
12	Exploratory phase Ⅲ study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer 显示文摘	Neijt JP Engelhom SA Tuxen MK	2008	J Clin Oncol2008，18，17：	1
13	A meta - analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival as main objective 显示文摘	Voest EE van Houwelingen JC Neijt JP	1989	Eur J Cancer1989，25，：	1
14	New therapy for ovarian cancer显示文摘	Neijt JP	1996	N Eng J Med1996，334，：	1
15	Concerted involvement of Cdx/Hox genes and Wnt signaling in morphogenesis of the caudal neu- ral tube and cloacal derivatives from the posterior growth zone 显示文摘	van-de-Ven C Bialecka M Neijts R	2011	Development2011，138，16：	1
16	Exploratory phase II study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer显示文摘	Neijt JP Engelholm SA Tuxen MK	2000	J Clin Oncol2000，18，17：	1
17	Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastma cells labeled with ICS 205 -930显示文摘	Neijt HC Wober C Palacios JM	1989	J Recept Res1989，9，1：	1
18	Palacios: 5-HT3 recognition sites in the central and peripheniral nervius system: autoradiographic and radioligand binding studies 显示文摘	Wober C Neijt HC	1989	Br J Pharmacol1989，96，9：	1
19	New therapy for ovarian cancer显示文摘	Neijt JP	2005	N Eng J Med2005，334，25：	1
20	First Line Chemotherapy with Carboplatin Plus Paclitaxel in Advanced Ovarian Cancer - a New Standard of Care?显示文摘	A. du Bois J. P. Neijt J. T. Thigpen	1999	Annals of Oncology1999，，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示